268 related articles for article (PubMed ID: 11911112)
21. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
Jones LP; Erdman DD; Anderson LJ
J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?
Ortega-Hernandez OD; Cuccia M; Bozzini S; Bassi N; Moscavitch S; Diaz-Gallo LM; Blank M; Agmon-Levin N; Shoenfeld Y
Ann N Y Acad Sci; 2009 Sep; 1173():589-99. PubMed ID: 19758204
[TBL] [Abstract][Full Text] [Related]
23. [Parvovirus B19 as a cause of acute liver symptoms in adults].
Hillingsø JG; Jensen IP; Tom-Petersen L
Ugeskr Laeger; 1998 Oct; 160(44):6355-6. PubMed ID: 9810242
[TBL] [Abstract][Full Text] [Related]
24. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
[TBL] [Abstract][Full Text] [Related]
25. Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients.
Frémont M; Metzger K; Rady H; Hulstaert J; De Meirleir K
In Vivo; 2009; 23(2):209-13. PubMed ID: 19414405
[TBL] [Abstract][Full Text] [Related]
26. Increased seroprevalence of parvovirus B 19 IgG in complex regional pain syndrome is not associated with antiendothelial autoimmunity.
Gross O; Tschernatsch M; Bräu ME; Hempelmann G; Birklein F; Kaps M; Madlener K; Blaes F
Eur J Pain; 2007 Feb; 11(2):237-40. PubMed ID: 16545972
[TBL] [Abstract][Full Text] [Related]
27. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
Lehmann HW; Knöll A; Küster RM; Modrow S
Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
[TBL] [Abstract][Full Text] [Related]
28. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection.
Nyman M; Skjöldebrand-Sparre L; Broliden K
J Perinat Med; 2005; 33(2):176-8. PubMed ID: 15843271
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
30. [Parvovirus B19 infection in patients with congenital blood coagulation disorders].
Aguilar Franco C; Lucía Cuesta JF; Ferrer Torres J; Omeñaca Teres M
Med Clin (Barc); 1997 May; 108(17):641-6. PubMed ID: 9312580
[TBL] [Abstract][Full Text] [Related]
31. [Parvovirus B19 infections in Germany 1987-1988].
Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients.
Mauser-Bunschoten EP; Zaaijer HL; van Drimmelen AA; de Vries S; Roosendaal G; van den Berg HM; Lelie PN
Vox Sang; 1998; 74(4):225-7. PubMed ID: 9691402
[TBL] [Abstract][Full Text] [Related]
33. Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult.
Larroche C; Scieux C; Honderlick P; Piette AM; Morinet F; Blétry O
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):739-42. PubMed ID: 12415473
[TBL] [Abstract][Full Text] [Related]
34. Antibody-mediated opsonization of red blood cells in parvovirus B19 infection.
Chehadeh W; Halim MA; Al-Nakib W
Virology; 2009 Jul; 390(1):56-63. PubMed ID: 19450862
[TBL] [Abstract][Full Text] [Related]
35. Clinical interpretation of antineutrophil cytoplasmic antibodies: parvovirus B19 infection as a pitfall.
Hermann J; Demel U; Stünzner D; Daghofer E; Tilz G; Graninger W
Ann Rheum Dis; 2005 Apr; 64(4):641-3. PubMed ID: 15485998
[TBL] [Abstract][Full Text] [Related]
36. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
37. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases.
Gallinella G; Zuffi E; Gentilomi G; Manaresi E; Venturoli S; Bonvicini F; Cricca M; Zerbini M; Musiani M
J Med Virol; 2003 Sep; 71(1):135-9. PubMed ID: 12858419
[TBL] [Abstract][Full Text] [Related]
38. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
[TBL] [Abstract][Full Text] [Related]
39. Persistent parvovirus B19 viremia with chronic arthralgia treated with ascorbic acid: a case report.
Lallement A; Zandotti C; Brouqui P
J Med Case Rep; 2015 Jan; 9(1):1. PubMed ID: 25560323
[TBL] [Abstract][Full Text] [Related]
40. Polymyalgia rheumatica is not seasonal in pattern and is unrelated to parvovirus b19 infection.
Peris P
J Rheumatol; 2003 Dec; 30(12):2624-6. PubMed ID: 14719204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
